Sale process will help enable next stage of product development Secures up to $10.25 million in new financing to support ongoing business operations SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- ...

Biora Therapeutics (BIOR) has reached an agreement with certain of its prepetition creditors to provide financing to support a chapter 11 sale process, which will ultimately lead to a strengthened ...

Biora Therapeutics, a reputable biotech firm listed on the NASDAQ under the ticker BIOR, recently made waves in the financial world by voluntarily filing a petition on December 27, 2024, under Chapter ...

Biora Therapeutics announces a Chapter 11 filing to support a sale process and secure up to $10.25 million in financing. Biora Therapeutics, Inc., a biotech company focused on developing smart ...

Biora Therapeutics (BIOR) has reached an agreement with certain of its prepetition creditors to provide financing to support a chapter 11 sale process, which will ultimately lead to a strengthened ...

Throughout this process, Biora expects to operate its business as usual and in the ordinary course as the Lenders have agreed to provide the Company with a debtor in possession financing facility ...

Sale process will help enable next stage of product development Secures up to $10.25 million in new financing to support ongoing business operations SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora ...

SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (“Biora” or the “Company”), a biotech company developing smart pill-based therapeutic ...